The burgeoning food and beverage industry in Asia-Pacific is a primary driver for the industrial enzymes market. Enzymes play a crucial role in enhancing the quality, shelf-life, and nutritional value of food products. With increasing urbanization, rising disposable incomes, and changing dietary preferences, there is a substantial demand for processed and convenience foods. The expansion of food processing plants in countries like China and India, where companies are increasingly incorporating enzymes to improve product offerings. The industrial enzymes market in the Asia-Pacific region is witnessing substantial growth, driven by the expanding diversity of enzyme applications in the food and beverage industry. Enzymes, as biological catalysts, play a critical role in enhancing the efficiency, quality, and sustainability of food and beverage production. Their application spans various processes, including fermentation, brewing, dairy processing, baking, and juice clarification, among others.
Access Full Report @ https://www.databridgemarketresearch.com/reports/asia-pacific-industrial-enzymes-market
Data Bridge Market Research analyzes that the Asia-Pacific Industrial Enzymes Market is expected to reach USD 3.38 billion by 2031 from USD 1.96 billion in 2023, growing with a substantial CAGR of 7.0% in the forecast period of 2024 to 2031.
Key Findings of the Study
Rise in Demand for Enzymes in Pharmaceuticals and Healthcare Industry
The industrial enzymes market in the Asia-Pacific region is experiencing robust growth, fueled by the rising demand for enzymes in the pharmaceuticals and healthcare industry. Enzymes, due to their specificity and efficiency, are integral to various medical applications, including drug formulation, disease diagnosis, and therapeutic treatments.
Enzymes are crucial in the development and formulation of a wide range of pharmaceuticals. They enhance the bioavailability and efficacy of drugs, enabling targeted and efficient drug delivery. Enzyme-based drug formulations are particularly significant in treating metabolic disorders, cancers, and infectious diseases.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion
|
|
Segments Covered
|
Type (Carbohydrases, Hydrolases, Oxidoreductases, Transferases, Lyases, Isomerases, Polymerase, Nucleases, and Others), Source (Microorganism-Based, Plant-Based, and Animal-Based), Fermentation Technique (Submerged Fermentation and Solid-Substrate Fermentation), Form (Liquid, Dry, Granular, Gel, and Others), Application (Food & Beverages, Detergents, Animal Feed, Personal Care & Cosmetics, Pharmaceutical, Diagnostics & Therapeutic Application, Textiles & Leather, Wastewater Treatment, Paper & Pulp, Biofuel, and Others)
|
|
Countries/Region Covered
|
South East Asia, China, South Asia, Japan, South Korea, Australia, New Zealand, Rest of Asia-Pacific
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd (Switzerland), Novozymes A/S, part of Novonesis Group (Denmark), AB Enzymes (Germany), dsm-firmenich (Switzerland), Amano Enzyme Inc. (Japan), BASF SE (Germany), Kerry Group plc. (Ireland), Adisseo (U.S.), Advanced Enzyme Technologies (India), Novus International, Inc. (U.S.), Tex Bioscienes (P) Ltd. (India), Stern Ingredients Asia-Pacific. (Singapore), Aumgene Biosciences (India), HBI Enzymes Inc. (Japan), Chaoyang Starzyme Bioengineering Co., Ltd (China), EnzymeTech Pte Ltd (Singapore), HUNAN LERKAM BIOLOGY CORP., LTD. (China), Ultreze Enzymes (India), Megazyme Ltd. (Acquired by NEOGEN Corporation) (Ireland), and Creative Enzymes (U.S.) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand
|
Segment Analysis
Asia-Pacific industrial enzymes market is segmented into five notable segments based on type, source, fermentation technique, form, and application.
- On the basis of type, the Asia-Pacific industrial enzymes market is segmented into carbohydrases, hydrolases, oxidoreductases, transferases, lyases, isomerases, polymerase, nucleases, and others
In 2024, the carbohydrases segment is expected to dominate the Asia-Pacific Industrial Enzymes Market
In 2024, the carbohydrases segment is expected to dominate the market with a market share of 32.41% because carbohydrases have extensive applications across multiple industries, including food and beverage, textiles, detergents, biofuels, and pharmaceuticals. For instance, amylases are crucial in brewing and baking, cellulases are used in textile processing and biofuel production, and pectinases are employed in fruit juice clarification.
- On the basis of source, the Asia-Pacific industrial enzymes market is segmented into microorganism-based, plant-based, and animal-based
In 2024, the microorganism-based segment is expected to dominate the Asia-Pacific Industrial Enzymes Market
In 2024, the microorganism-based segment is expected to dominate the market with a 74.53% market share due to their high production efficiency, cost-effectiveness, and adaptability through genetic engineering, ensuring consistent and scalable supply for diverse applications.
- On the basis of fermentation technique, the Asia-Pacific industrial enzymes market is segmented into submerged fermentation and solid-substrate fermentation. In 2024, the submerged fermentation segment is expected to dominate with a market share of 65.54%
- On the basis of form, the Asia-Pacific industrial enzymes market is segmented into liquid, dry, granular, gel, and others. In 2024, the liquid segment is expected to dominate with a market share of 39.60%
- On the basis of application, the Asia-Pacific industrial enzymes market is segmented into food & beverages, detergents, animal feed, personal care & cosmetics, pharmaceutical, diagnostics & therapeutic application, textiles & leather, wastewater treatment, paper & pulp, biofuel and others. In 2024, the food & beverages segment is expected to dominate with a market share of 32.76%
Major Players
Data Bridge Market Research analyzes F. Hoffmann-La Roche Ltd (Switzerland), Novozymes A/S, part of Novonesis Group (Denmark), AB Enzymes (Germany), dsm-firmenich (Switzerland), and Amano Enzyme Inc. (Japan) as the major players in the Asia-Pacific industrial enzymes market.
Market Developments
- In June 2024, the F. Hoffmann-La Roche Ltd company announced the launch of latest product, NucleoMix, 400 mM (100 mM each) designed to meet the specific needs of manufacturers of molecular IVD assays, NucleoMix, 400 mM, is set to advance the field of molecular diagnostics
- In March 2024, Novus International, Inc. acquired U.S.-based enzyme company BioResource International, Inc., gaining ownership of BRI’s products, intellectual property, and facilities. This acquisition will enhance customer service, expand their innovation pipeline, and provide more options for feed additives to support animal health and profitability
- In June 2023, Creative Enzymes presented at BIO 2023. The BIO International Convention draws over 14,000 biotechnology and pharmaceutical industry leaders for a week dedicated to intensive networking, exploring new opportunities, and fostering promising partnerships
- In May 2023, Creative Enzymes presented at PEGS 2023. The PEGS Boston Summit is the leading event for biologics, featuring comprehensive programming on every facet of biologic drug development. It includes detailed presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytics, immunogenicity, and more
- In April 2023, Creative Enzymes participated in the AACR Annual Meeting. This meeting is the central gathering for the cancer research community, uniting scientists, clinicians, healthcare professionals, survivors, patients, and advocates to exchange the latest breakthroughs in cancer science and medicine
Regional Analysis
Geographically, the regions covered in the Asia-Pacific industrial enzymes market report are South East Asia, China, South Asia, Japan, South Korea, Australia, New Zealand, and rest of Asia-Pacific. South East Asia region is further segmented by countries into Singapore, Vietnam, Thailand, Malaysia, Indonesia, Taiwan, Philippines, and rest of South East Asia. South Asia is further segmented by countries into India, Bangladesh, Pakistan, Sri Lanka, and rest of South Asia.
As per Data Bridge Market Research analysis:
South East Asia is the dominant and the fastest-growing region in the Asia-Pacific Industrial Enzymes Market
South East Asia is expected to dominate the market due to its rapid industrialization, growing food and beverage sector, increasing investments in biotechnology and sustainable practices and rise in demand for enzymes in pharmaceuticals and healthcare industry.
For more detailed information about the Asia-Pacific industrial enzymes market report, click here – https://www.databridgemarketresearch.com/reports/asia-pacific-industrial-enzymes-market
